Kaneh Bosm BioTechnolgy Inc.
CNSX : KBB

Kaneh Bosm BioTechnolgy Inc.

November 12, 2014 08:00 ET

Kaneh Bosm BioTechnology Retains LP Application Consultant and Announces Appointment of a New Member to the Advisory Board

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 12, 2014) -

NOT FOR DISSEMINATION IN THE UNITED STATES

Kaneh Bosm BioTechnolgy Inc. (CSE:KBB) ("Kaneh Bosm" or the "Company") has retained the services of Trichome Consulting Services Inc. (TCSI) to assist the Company with our Licensed Producer (LP) application to Health Canada. TCSI will develop a comprehensive LP application for medical Cannabis production, import/export, and sales & distribution in Canada. TCSI's application will meet and surpass all of Health Canada's requirements as per the MMPR LP regulations.

TCSI and its team of certified professionals will work closely with Kaneh Bosm to customize the Operational Procedures, Quality Assurance programs, Security Designs & Site Plans, Standard Operating Procedures (SOPs), Corporate Requirements, Record Keeping, Notification Letters, Security Clearance, plus Activities and Substances to be specified on the License.

Kaneh Bosm is pleased to introduce another member to our team in the capacity of Strategic Advisor. This gentleman has extensive international business experience and is very motivated to apply his energy to this growing company.

Mr. Stacy Quinney is a dynamic and accomplished serial entrepreneur with extensive experience working in high-growth, high-tech, and emerging markets since 1994. Born in and raised in western Canada, he has been a resident of Eastern Europe since 1996 and has successfully founded, invested in, raised funds for, and participated in private/public equity and investment banking transactions totaling over USD 250 Million.

His contract negotiation and execution experience includes complex service agreements with multinational corporations as well as structuring and closing of investment banking transactions both as an advisor and as a principal. Mr. Quinney possesses an extensive background in corporate development, international trade and commerce, including inter-governmental relations. His broad based economic knowledge and specific technical acumen spans a multitude of business segments including import, export, agriculture, mining, telecom, manufacturing, retail/wholesale fast moving consumer goods (FMCG), distribution & logistics and IPO's.

Mr. Quinney was responsible for founding First Romanian Distribution (FRD) in 1997, which became the successfully funded First Logistics and Distribution (FLD) in Romania, a company that had turnover in excess of USD 80M. FLD employed over 500 staff with 20 warehouses, and 300 trucks at its peak. Among FLD's clients were Nestle, Masterfoods, Gillette, and Unilever. He successfully divested the company's holdings to a London based Private equity Firm in 2005.

Mr. Quinney is active as a principal and consultant for private and publicly listed Canadian, US, and International entities. He has held various senior executive and board level positions domestically and internationally.

His complete bio is available at www.kanehbosmbiotech.com.

"I am very pleased to have my esteemed colleague Mr. Quinney join our "Cannabis Dream Team", Michael Martinz, President of Kaneh Bosm, remarks. "Mr. Quinney is very motivated to apply his energy to assist the development of this exciting new venture. With his extensive business background, and international network he is a very welcome addition."

On behalf of the Board of Directors of Kaneh Bosm Inc.

Michael Martinz, President, Director

Rudy de Jonge, CEO, Director

THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.

This news release includes certain statements that may be deemed "forward-looking statements". The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "would", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com.

Contact Information

  • Kaneh Bosm BioTechnology Inc.
    810 - 675 West Hastings Street
    Vancouver, BC V6B 1N2
    604.782.4191
    604.637.9614 (FAX)